2021-01-07,"Onconova Therapeutics, Inc. Announces $8.7 Million Public Offering"
2020-12-21,Onconova Therapeutics Announces FDA Permission for Study to Proceed Under its Investigational New Drug Application for Multi-kinase CDK4/6 Inhibitor ON 123300
2020-12-01,Return On Capital Employed Overview: Onconova Therapeutics
2020-11-23,Onconova Therapeutics Files Investigational New Drug Application for Multi-kinase CDK4/6 Inhibitor ON 123300
2020-11-12,Onconova Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
2020-11-12,"Onconova Therapeutics, Inc. to Host Earnings Call"
2020-11-05,"Onconova Therapeutics to Provide Corporate Update and Third Quarter 2020 Financial Results on November 12, 2020"
2020-10-13,Onconova Therapeutics to Present Update During the 2020 BIO Investor Forum Digital Event
2020-10-05,5 Value Stocks To Watch In The Healthcare Sector
2020-09-21,Looking Into Onconova Therapeutics's Return On Capital Employed
2020-09-21,Onconova Therapeutics Announces Initiation of a Phase 1 Clinical Trial of ON 123300 in China by Partner HanX Biopharmaceuticals
2020-09-09,Onconova Therapeutics Announces Participation at Upcoming Virtual Events
2020-08-31,Overview Of Value Stocks In The Healthcare Sector
2020-08-31,"Onconova Therapeutics Announces Election of James J. Marino, JD, MBA as Chairman of the Board of Directors"
2020-08-26,"After an Unfortunate Surprise, Can Onconova Bounce Back? Analyst Weighs In"
2020-08-25,"Onconova's Cancer Study Fails to Meet Endpoint, Shares Down"
2020-08-24,Return On Capital Employed Overview: Onconova Therapeutics
2020-08-24,Onconova Therapeutics Announces Topline Results from the Pivotal Phase 3 INSPIRE Trial
2020-08-17,5 Value Stocks To Watch In The Healthcare Sector
2020-08-12,Onconova Therapeutics: Q2 Earnings Insights
2020-08-12,Onconova Therapeutics Highlights Corporate Progress and Reports Second Quarter 2020 Financial Results
2020-08-07,"Onconova Therapeutics to Provide Corporate Update and Second Quarter 2020 Earnings on August 12, 2020"
2020-08-04,Onconova Therapeutics Announces Compliance with Nasdaq Bid Price Requirement
2020-08-03,Onconova (ONTX) to Report Q2 Earnings: What's in the Offing?
2020-07-29,Onconova Therapeutics Announces that the Required Number of Survival Events Has Been Reached for the Pivotal Phase 3 INSPIRE Trial Data Analysis
2020-07-27,Onconova Therapeutics Submits Application for Rigosertib to Participate in Federally Funded Human Studies in COVID-19 Disease
2020-07-23,Onconova Therapeutics Announces Publication of Preclinical Data Supporting Rigosertibs Mechanism of Action as a Targeted Anticancer Therapy
2020-07-07,Onconova Therapeutics Announces Publication of Phase 1 Results in Leukemia Research Exploring Oral Rigosertib in Combination with Azacitidine in Higher-Risk MDS
2020-06-23,Onconova Initiates Phase I/IIa Study on Lung Cancer Candidate
2020-06-23,Onconova Therapeutics Announces Participation in Noble Capital Markets Investor Webinar
2020-06-22,Onconova Therapeutics Announces the Initiation of a Phase 1/2a Study of Rigosertib plus Nivolumab for the Treatment of KRAS+ Lung Adenocarcinoma
2020-06-12,Onconova Therapeutics Announces Presentation at the 25th Congress of the European Hematology Association (EHA)
2020-06-08,Onconova Therapeutics Announces Presentation at BIO Digital 2020
2020-05-28,3 Strong Buy Penny Stocks That Offer Massive Potential Gains
2020-05-18,Edited Transcript of ONTX earnings conference call or presentation 14-May-20 8:30pm GMT
2020-05-14,Onconova Therapeutics Provides Corporate Update and Reports First Quarter 2020 Financial Results
2020-05-11,Onconova Therapeutics Announces Virtual Format for 2020 Annual Meeting of Stockholders
2020-05-07,"Onconova Therapeutics to Provide Corporate Update and First Quarter 2020 Earnings on May 14, 2020"
2020-04-27,Onconova Therapeutics Strengthens Board of Directors with Nomination of Life Sciences Industry Veteran
2020-04-07,How 3 Philly-area biopharmaceutical firms are working through coronavirus challenges
2020-04-02,Edited Transcript of ONTX earnings conference call or presentation 24-Mar-20 8:30pm GMT
2020-03-24,"Onconova Therapeutics Announces Completion of Enrollment of Phase 3 INSPIRE Trial, Provides a Corporate Update, and Reports 2019 Financial Results"
2020-03-18,Onconova Therapeutics to Provide Corporate Update and Full Year 2019 Financial Results
2020-03-13,Will Onconova Therapeutics Continue to Surge Higher?
2020-03-02,Onconova (ONTX) to Report Q4 Earnings: What's in Store?
2020-02-21,"The Zacks Analyst Blog Highlights: Onconova Therapeutics, Abeona Therapeutics, Proteostasis Therapeutics, Applied Therapeutics and Ennis"
2020-02-20,"Onconova Therapeutics, Inc. (ONTX) Shares March Higher, Can It Continue?"
2020-02-20,US Dollar Flexes Muscles Against Other Currencies: 5 Winners
2020-02-19,"The Zacks Analyst Blog Highlights: Apple, Eagle Bancorp Montana, Onconova Therapeutics, Proteostasis Therapeutics and Abeona Therapeutics"
2020-02-18,Coronavirus to Hit Apple Sales: Invest in Domestic Producers
2020-02-18,Onconova Therapeutics Announces Participation in Two Upcoming International Conferences
2020-02-10,"Onconova Therapeutics to Present Update at Noble Capital Markets Sixteenth Annual Investor Conference in Hollywood, FL"
2020-02-04,Onconova Therapeutics to Present Update at the 2020 BIO CEO & Investor Conference in New York City
2020-01-23,Onconova shares rise after company regains rights to drug in China
2020-01-23,Onconova Therapeutics Regains Rigosertib Rights in Greater China
2020-01-03,"Onconova Therapeutics, Inc. Announces Closing of $10 Million Registered Direct Offering of Common Stock Priced At-The-Market"
2020-01-02,Bucks County biopharm firm plans $10M stock sale
2019-12-31,"Onconova Therapeutics, Inc. Announces $10 Million Registered Direct Offering Priced At-The-Market"
2019-12-23,"Onconova Therapeutics, Inc. (ONTX) Is Burning These Hedge Funds"
2019-12-19,"Onconova Therapeutics, Inc. Announces Closing Of $5.0 Million Registered Direct Offering Priced At-The-Market"
2019-12-18,"Onconova Therapeutics, Inc. Announces $5.0 Million Registered Direct Offering Priced At-the-Market"
2019-12-18,Onconova Therapeutics Announces Exclusive License Agreement with Specialised Therapeutics for Rigosertib in Australia and New Zealand
2019-12-17,Onconova Therapeutics and Pint Pharma Announce Brazilian Health Authority Approval for Initiating INSPIRE Trial with Intravenous Rigosertib in Higher-Risk Myelodysplastic Syndromes in Brazil
2019-12-10,"Onconova Therapeutics, Inc. Announces Closing of $5.0 Million Registered Direct Offering Priced At-the-Market"
2019-12-09,Onconova Therapeutics Announces Data on Genomic Profiles of Higher Risk Myelodysplastic Syndromes Patients Refractory to Azacitidine Therapy Enrolled into the Pivotal INSPIRE Trial and Updated Oral Rigosertib Data Informing a Potential Adaptive Clinical Trial Design at the American Society of Hematology 2019 Annual Meeting
2019-12-09,"Onconova Therapeutics, Inc. Announces $5.0 Million Registered Direct Offering Priced At-the-Market"
2019-12-07,"The Week Ahead In Biotech: ASH Presentations Pick Up Steam, Correvio Awaits Adcom Ruling"
2019-12-06,"Benzinga Pro's Top 5 Stocks To Watch For Fri., Dec. 6, 2019: TSLA, ONTX, XHB, BIG, SFIX"
2019-12-06,Inceptua Medicines Access and Onconova Therapeutics Announce Pre-approval Access Collaboration for Rigosertib in Selected Countries Outside the US
2019-11-25,"Onconova Therapeutics, Inc. Announces Closing of $11.0 Million Public Offering"
2019-11-22,"Bucks County biopharm firm enters into licensing deal, embarks on stock sale"
2019-11-21,"Onconova Therapeutics, Inc. Announces $11.0 Million Public Offering"
2019-11-21,Onconova Therapeutics Announces Exclusive License Agreement with Knight Therapeutics for Rigosertib in Canada
2019-11-07,Onconova Announces Five Presentations on Rigosertib in Myelodysplastic Syndromes (MDS) at the ASH 2019 Annual Meeting & Exposition
2019-10-24,Onconova Affirms Planned Completion of Pivotal Phase 3 INSPIRE Study of Rigosertib in Myelodysplastic Syndromes by 1H20 And Provides Research & Development Update
2019-09-24,Bucks County biopharm firm opts for private over public stock sale
2019-09-23,"Onconova Therapeutics, Inc. Announces $3.4 Million Registered Direct Offering of Common Stock"
2019-09-19,"The Daily Biotech Pulse: China Biologics Receives Buyout Offer, Provention Bio Offering, Exagen IPO"
2019-09-18,Onconova Therapeutics Announces Termination of Proposed Public Offering
2019-09-16,Onconova Therapeutics Announces Presentation on Rigosertib at the RAS-Targeted Drug Discovery Summit
2019-08-23,Edited Transcript of ONTX earnings conference call or presentation 14-Aug-19 1:00pm GMT
2019-08-14,"Onconova Therapeutics, Inc. Reports Business Highlights and Second Quarter 2019 Financial Results"
2019-08-12,Onconova Therapeutics and Mission Bio Partner to Advance Precision Oncology Clinical Trials Employing Single-Cell Genomics
2019-08-07,"Onconova Therapeutics, Inc. to Provide Corporate Update and Second Quarter 2019 Financial Results"
2019-08-06,Onconova Therapeutics (ONTX) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
2019-06-10,Onconova Therapeutics Announces Presentations at the 24th Congress of the European Hematology Association
2019-05-30,Edited Transcript of ONTX earnings conference call or presentation 14-May-19 1:00pm GMT
2019-05-28,Onconova Therapeutics Announces Presentations at Three Upcoming Conferences
2019-05-14,"Onconova Therapeutics, Inc. Reports Business Highlights and First Quarter 2019 Financial Results"
2019-05-13,Newtown biopharm firm could reap $50M from Chinese licensing deal
2019-05-13,Onconova Therapeutics Announces License Agreement with HanX Biopharmaceuticals to Develop and Commercialize Rigosertib in Greater China
2019-05-07,"Onconova Therapeutics, Inc. to Provide Corporate Update and First Quarter 2019 Financial Results"
2019-05-06,"Onconova Therapeutics Announces Presentations at the 15th International Symposium on Myelodysplastic Syndromes (MDS 2019) in Copenhagen, Denmark"
2019-04-02,"Onconova Therapeutics to Present Update at the 2019 HCW Global Life Sciences Conference in London, April 7-9"
2019-04-02,Edited Transcript of ONTX earnings conference call or presentation 26-Mar-19 1:00pm GMT
2019-03-26,"Onconova Therapeutics, Inc. Reports Business Highlights and Full Year 2018 Financial Results"
2019-03-25,Onconova Achieves Over 75 Percent of Planned Enrollment in Pivotal Phase 3 INSPIRE Study of Rigosertib in Myelodysplastic Syndromes
2019-03-19,"Onconova Therapeutics, Inc. to Provide Corporate Update and Full Year 2018 Financial Results"
2019-03-12,"Onconova Therapeutics, Inc. to Participate at the 31st Annual ROTH Conference March 17-19, 2019 in Orange County, CA"
2019-02-04,"Onconova Therapeutics, Inc. to Present Corporate Update at the BIO CEO & Investor Conference in New York City"
